Edition:
United Kingdom

Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,152.00GBp
11 Dec 2018
Change (% chg)

4.00 (+0.19%)
Prev Close
2,148.00
Open
2,164.00
Day's High
2,172.00
Day's Low
2,128.00
Volume
106,234
Avg. Vol
413,259
52-wk High
3,180.48
52-wk Low
1,956.00

Chart for

About

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The... (more)

Overall

Beta: 0.67
Market Cap(Mil.): £2,007.26
Shares Outstanding(Mil.): 93.40
Dividend: 15.33
Yield (%): --

Financials

  DPH.L Industry Sector
P/E (TTM): 76.96 31.13 33.63
EPS (TTM): 0.28 -- --
ROI: 4.94 15.55 15.02
ROE: 9.07 16.92 16.60

Dechra Pharma says to implement hard Brexit plan

Veterinary drugs producer Dechra Pharmaceuticals said on Monday it was moving ahead with plans for a hard Brexit, stressing the financial impact should be "immaterial" but spooking investors worried about revenue and operations after next year's split.

03 Sep 2018

UPDATE 1-UK's Dechra Pharma says to implement hard Brexit plan

Sept 3 Veterinary drugs producer Dechra Pharmaceuticals said on Monday it was moving ahead with plans for a hard Brexit, stressing the financial impact should be "immaterial" but spooking investors worried about revenue and operations after next year's split.

03 Sep 2018

UK's Dechra Pharma says to implement hard Brexit plan

Sept 3 British veterinary firm Dechra Pharmaceuticals said on Monday it would implement a plan to navigate a hard Brexit.

03 Sep 2018

Earnings vs. Estimates